Compare ESP & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESP | CVRX |
|---|---|---|
| Founded | 1928 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.4M | 160.8M |
| IPO Year | 1995 | 2021 |
| Metric | ESP | CVRX |
|---|---|---|
| Price | $57.61 | $5.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $64.00 | $10.50 |
| AVG Volume (30 Days) | 42.5K | ★ 354.3K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.50% | N/A |
| EPS Growth | N/A | ★ 23.02 |
| EPS | ★ 2.74 | N/A |
| Revenue | $43,950,872.00 | ★ $56,651,000.00 |
| Revenue This Year | $10.30 | $17.17 |
| Revenue Next Year | $10.00 | $17.69 |
| P/E Ratio | $21.00 | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $36.00 | $4.37 |
| 52 Week High | $74.77 | $11.30 |
| Indicator | ESP | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.63 | 33.69 |
| Support Level | $52.36 | $5.06 |
| Resistance Level | $61.58 | $8.10 |
| Average True Range (ATR) | 3.82 | 0.54 |
| MACD | -0.96 | -0.01 |
| Stochastic Oscillator | 15.58 | 28.36 |
Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.